Antitumor 2-(aminocarbonyl)-1,2-bis(methylsulfonyl)-1-(2-chloroethyl)-hydrazines

Journal of Medicinal Chemistry

Volumn 39, Issue 3, 1996, Pages 796-801

  Shyam, Krishnamurthy ^a   Penketh, Philip G ^a   Loomis, Regina H ^a   Rose, William C ^b   Sartorelli, Alan C ^a  

^a YALE CANCER CENTER   (United States)

^b BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 (2 CHLOROETHYL) 2 [[(2 CHLOROETHYL)AMINO]CARBONYL] 1,2 BIS(METHYLSULFONYL)HYDRAZINE; ANTINEOPLASTIC AGENT; CARMUSTINE; CYCLOPHOSPHAMIDE; HYDRAZINE DERIVATIVE; LOMUSTINE; MITOMYCIN C; NITROSOUREA DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; DRUG POTENCY; DRUG SYNTHESIS; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LEUKEMIA CELL; LUNG CANCER; MELANOMA; MOUSE; NONHUMAN; RETICULOSARCOMA;

ANIMALS; ANTINEOPLASTIC AGENTS; HUMANS; LUNG NEOPLASMS; MAGNETIC RESONANCE SPECTROSCOPY; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; NITROSOUREA COMPOUNDS; SARCOMA, EXPERIMENTAL;

EID: 0030048394     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm9505021     Document Type: Article

References (32)

1. DeVita, V. T.; Carbone, P. P.; Owens, A. H., Jr.; Gold, G. L.; Krant, M. J.; Edmonson, J. Clinical trials with 1,3-bis(2-chloroethyl)-1-nitrosourea, NSC-409962. Cancer Res. 1965, 25, 1876-1881.
2. Nissen, N. I.; Pajak, T. F.; Glidewell, O.; Pedersen-Bjergaard, J.; Stutzman, L.; Falkson, G.; Cuttner, J.; Blom, J.; Leone, L.; Sawitsky, A.; Coleman, M.; Haurani, F.; Spurr, C. L.; Harley, J. B.; Seligman, B.; Cornell, C., Jr.; Henry, P.; Senn, H.; Brunner, K.; Martz, G.; Maurice, P.; Bank, A.; Shapiro, L.; James, G. W.; Holland, J. F. Comparative study of a BCNU containing 4-drug program versus MOPP versus 3-drug combinations in advanced Hodgkin's disease. Cancer 1979, 43, 31-40.
3. Montgomery, J. A.; James, R.; McCaleb, G. S.; Johnston, T. P. The modes of decomposition of 1,3-bis(2-chloroethyl)-1-nitrosourea and related compounds. J. Med. Chem. 1967, 10, 668-674.
4. Montgomery, J. A.; James, R.; McCaleb, G. S.; Kirk, M. C.; Johnston, T. P. Decomposition of N-(2-chloroethyl)-N-nitrosoureas in aqueous media. J. Med. Chem. 1975, 18, 568-571.
5. Weinkam, R. J.; Lin, H.-S. Reactions of 1,3-bis(2-chloroethyl)-1-nitrosourea and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea in aqueous solution. J. Med. Chem. 1979, 22, 1193-1198.
6. Brundrett, R. B. Chemistry of nitrosoureas. Intermediacy of 4,5-dihydro-1,2,3-oxadiazole in 1,3-bis(2-chloroethyl)-1-nitrosourea decomposition. J. Med. Chem. 1980, 23, 1245-1247.
7. Kohn, K W. In Recent Results in Cancer Research; Carter, S. K., Sakurai, Y., Umezawa, H., Eds.; Springer: Berlin, 1981; Vol. 76, p 141.
8. Shealy, Y. F.; Krauth, C. A.; Laster, W. R., Jr. 2-Chloroethyl (methanesulfonyl)methanesulfonate and related (methylsulfonyl)methanesulfonates. Antineoplastic activity in vivo. J. Med. Chem. 1984, 27, 664-670.
9. Montgomery, J. A., personal communication, cited by Gibson, N. W.; Hartley, J. A.; Strong, J. M.; Kohn, K. W. 2-Chloroethyl (methylsulfonyl)methanesulfonate (NSC-338947), a more selective DNA alkylating agent than the chloroethylnitrosoureas. Cancer Res. 1986, 46, 553-557.
10. Pelfrene, A.; Mirvish, S. S.; Gold, B. Induction of malignant bone tumors in rats by 1-(2-hydroxyethyl)-1-nitrosourea. J. Natl. Cancer Inst. 1976, 56, 445-446.
11. Swenson, D. H.; Frei, J. V.; Lawley, P. D. Synthesis of 1-(2-hydroxyethyl)-1-nitrosourea and comparison of its carcinogenicity with that of 1-ethyl-1-nitrosourea. J. Natl. Cancer Inst. 1979, 63, 1469-1473.
12. Baril, B. B.; Baril, E. F.; Lazlo, J.; Wheeler, G. P. Inhibition of rat Liver DNA polymerase by nitrosoureas and isocyanates. Cancer Res. 1975, 35, 1-5.
13. Kann, H. E., Jr.; Kohn, K. W.; Lyles, J. M. Inhibition of DNA repair by 1,3-bis(2-chloroethyl)-1-nitrosourea breakdown product, 2-chloroethyl isocyanate. Cancer Res. 1974, 34, 398-402.
14. Kann, H. E., Jr.; Kohn, K. W.; Widerlite, L.; Gullion, D. Effects of 1,3-bis(2-chloroethyl)-1-nitrosourea and related compounds on nuclear RNA metabolism. Cancer Res. 1974, 34, 1982-1988.
15. Schallreuter, K. U.; Gleason, F. K.; Wood, J. M. The mechanism of action of the nitrosourea anti-tumor drugs on thioredoxin reductase, glutathione reductase and ribonucleotide reductase. Biochim. Biophys. Acta 1990, 1054, 14-20.
16. Colvin, M.; Brundrett, R. B.; Cowens, J. W.; Jardine, I.; Ludlum, D. B. A chemical basis for the antitumor activity of chloroethylnitrosoureas. Biochem. Pharmacol. 1976, 25, 695-699.
17. Wheeler, G. P.; Bowdon, B. J.; Grimsley, J.; Lloyd, H. H. Interrelationships of some chemical, physicochemical and biological activities of several 1-(2-haloethyl)-1-nitrosoureas. Cancer Res. 1974, 34, 194-200.
18. Panasci, L. C.; Green, D.; Nagourney, R.; Fox, P.; Schein, P. S. A structure-activity analysis of chemical and biological parameters of chloroethylnitrosoureas in mice. Cancer Res. 1977, 37, 2615-2618.
19. Gibson, N. W.; Hickman, J. A. The role of isocyanates in the toxicity of antitumor haloalkylnitrosoureas. Biochem. Pharmacol. 1982, 31, 2795-2800.
20. Newman, R. A.; Farquhar, D. Release of methyl isocyanate from the antitumor agent caracemide (NSC-253272). Invest. New Drugs 1987, 5, 267-271.
21. Slatter, J. G.; Davis, M. R.; Han, D.-H.; Pearson, P. G.; Baillie, T. A. Studies on the metabolic fate of caracemide, an experimental antitumor agent, in the rat. Evidence for the release of methyl isocyanate in vivo. Chem. Res. Toxicol. 1993, 6, 335-340.
22. Clinical brochure "Caracemide NSC 253272", Division of Cancer Treatment, National Cancer Institute, 1983.
23. Hill, D, L.; Kirk, M. C.; Struck, R. F. Microsomal metabolism of nitrosoureas. Cancer Res. 1975, 35, 296-301.
24. Lin, H.-S.; Weinkam, R. J. Metabolism of 1,3-bis(2-chloroethyl)-1-nitrosourea by rat hepatic microsomes. J. Med. Chem. 1981, 24, 761-763.
25. Potter, D. W.; Reed, D. J. Denitrosation of carcinostatic nitrosoureas by purified NADPH cytochrome P-450 reductase and rat liver microsomes to yield nitric oxide under anaerobic conditions. Arch. Biochem. Biophys. 1982, 216, 158-169.
26. Potter, D. W.; Reed, D. J. Involvement of FMN and phenobarbital cytochrome P-450 in stimulating a one-electron reductive denitrosation of 1-(2-chloroethyl)-3-(cyclohexyl)-1-introsourea catalyzed by NADPH-cytochrome P-450 reductase. J. Biol. Chem. 1983, 258, 6906-6911.
27. Smith, M. T.; Evans, C. G.; Doane-Setzer, P.; Castro, V. M.; Tahir, M. K.; Mannervik, B. Denitrosation of 1,3-bis(2-chloroethyl)-1-nitrosourea by class mu glutathione transferases and its role in cellular resistance in rat brain tumor cells. Cancer Res. 1989, 49, 2621-2625.
28. Berhane, K.; Hao, X-Y.; Egyhazi, S.; Hansson, J.; Ringborg, U.; Mannervik, B. Contribution of glutathione transferase M3-3 to 1,3-bis(2-chloroethyl)-1-nitrosourea resistance in a human non-small cell lung cancer cell line. Cancer Res. 1993, 53, 4257-4261.
29. Penketh, P. G.; Shyam, K.; Sartorelli, A. C. Studies on the mechanism of decomposition and structural factors affecting the aqueous stability of 1,2-bis(sulfonyl)-1-alkylhydrazines. J. Med. Chem. 1994, 37, 2912-2917.
30. Shyam, K.; Penketh, P. G.; Divo, A. A.; Loomis, R. H.; Patton, C. L.; Sartorelli, A. C. Synthesis and evaluation of 1,2,2-tris-(sulfonyl)hydrazines as antineoplastic and trypanocidal agents. J. Med. Chem. 1990, 33, 2259-2264.
31. Shyam, K.; Penketh, P. G.; Divo, A. A.; Loomis, R. H.; Rose, W. C.; Sartorelli, A. C. Synthesis and evaluation of 1-acyl-1,2-bis-(methylsulfonyl)-2-(2-chloroethyl)hydrazines as antineoplastic agents. J. Med. Chem. 1993, 36, 3496-3502.
32. Gehan, G. A. A generalized Wileoxan test for comparing arbitrarily singly-censored samples. Biometrika 1965, 52, 203-233.